Gastrointestinal consequences of lipopolysaccharide-induced lung inflammation.
Rachel M McQuadeMethma BandaraShanti DiwakarlaLauren SahakianMyat Noe HanMaryam Al ThaalibiMadeleine R Di NataleMarsha TanKiera H HarwoodElena K Schneider-FutschikAndrew JarnickiPublished in: Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2022)
Intratracheal LPS administration induces inflammation in the ileum that is associated with enhanced expression of EpCAM, decreased claudin-4 expression and increased goblet cell density, these changes may contribute to systemic inflammation that is known to accompany many inflammatory diseases of the lung.